PIK3CA and glioblastoma: Dactolisib (11) is a potentdual PI3K-mTOR inhibitor under investigation for the treatment ofsolid tumors and was recently proven to be an efficacious radiosensitizerand chemosensitizer in a preclinical mouse GBM model.